Novo Holdings A/S Q2 2017 Filing
Filed August 14, 2017
Portfolio Value
$835.8B
Holdings
21
Report Date
Q2 2017
Filing Type
13F-HR
All Holdings (21 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | INGNINOGEN INC | 3,549,320 | $338.7B | 40.52% | |
| 2 | ANABANAPTYSBIO INC | 3,033,504 | $72.6B | 8.69% | |
| 3 | XLRNACCELERON PHARMA INC | 1,553,937 | $47.2B | 5.65% | |
| 4 | —SPECTRANETICS CORP | 1,187,917 | $45.6B | 5.46% | |
| 5 | —DERMIRA INC | 1,534,664 | $44.7B | 5.35% | |
| 6 | CRVSCORVUS PHARMACEUTICALS INC | 3,244,046 | $39.3B | 4.70% | |
| 7 | —RA PHARMACEUTICALS INC | 2,031,562 | $38.1B | 4.56% | |
| 8 | —FLEXION THERAPEUTICS INC | 1,500,000 | $30.3B | 3.63% | |
| 9 | AKBAAKEBIA THERAPEUTICS INC | 1,814,289 | $26.1B | 3.12% | |
| 10 | —NABRIVA THERAPEUTICS PLC | 2,326,544 | $24.4B | 2.92% | |
| 11 | —OBSEVA SA | 2,710,760 | $23.2B | 2.77% | |
| 12 | MRUSMERUS N V | 1,410,417 | $22.4B | 2.67% | |
| 13 | KALVKALVISTA PHARMACEUTICALS INC | 2,901,927 | $21.4B | 2.56% | |
| 14 | RETAEURREATA PHARMACEUTICALS INC | 592,794 | $18.8B | 2.24% | |
| 15 | —APOLLO ENDOSURGERY INC | 1,351,972 | $10.7B | 1.28% | |
| 16 | —INVUITY INC | 1,363,848 | $9.9B | 1.18% | |
| 17 | VRNAVERONA PHARMA PLC | 740,740 | $8.6B | 1.03% | |
| 18 | —WRIGHT MED GROUP N V | 4,622,032 | $6.7B | 0.81% | |
| 19 | CRSPCRISPR THERAPEUTICS AG | 223,317 | $3.6B | 0.43% | |
| 20 | —HTG MOLECULAR DIAGNOSTICS INC | 1,230,399 | $3.3B | 0.39% | |
| 21 | XENEXENON PHARMACEUTICALS INC | 127,563 | $402.0M | 0.05% |